Earnings ·
Clarivate Reports Q3 Adjusted EPS of $0.21, Updates Full-Year Outlook Following LS&H Divestiture
CLVTClarivate PLC
Clarivate Plc reported third-quarter 2026 results with total revenues of $567.9 million and adjusted net income of $136.0 million, or $0.21 per diluted share. The company completed the divestiture of its Life Sciences & Healthcare segment for net cash proceeds of $488.4 million in October 2026. For the full year 2026, Clarivate updated its outlook excluding discontinued operations to project revenues between $1.965 billion and $1.985 billion, adjusted EBITDA between $865 million and $885 million, and free cash flow between $320 million and $340 million. The company also announced plans to use the divestiture proceeds and Q4 free cash flow to retire approximately $575 million to $600 million of senior notes. Clarivate operates as a leading global provider of transformative intelligence, offering data, insights, analytics, and workflow solutions in academia, government, and intellectual property sectors.